Ono Pharmaceutical (OPHLY) News Today $4.91 +0.07 (+1.45%) (As of 07/26/2024 ET) Add Compare Share Share HeadlinesStock AnalysisChartFinancialsHeadlinesSEC FilingsShort InterestStock AnalysisChartFinancialsHeadlinesSEC FilingsShort Interest All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 November 2021 October 2021 September 2021 August 2021 Time Period May 8, 2024 | markets.businessinsider.comOno Pharmaceutical is about to announce its earnings — here's what to expectApril 30, 2024 | reuters.comJapan's Ono Pharma says $2.4 bln Deciphera purchase 'first step' for global expansionApril 29, 2024 | msn.comDeciphera Catapults 72% After Ono Pharmaceutical Agrees To Buy It For $2.4 BillionApril 29, 2024 | marketwatch.comDeciphera Pharmaceuticals Gets $2.4B Buyout Offer From ONO PharmaceuticalApril 29, 2024 | markets.businessinsider.comONO To Acquire Deciphera; Total Equity Value Of Deal At Approx. $2.4 BlnApril 29, 2024 | reuters.comJapan's ONO Pharmaceutical to buy Deciphera for $2.4 billionMarch 6, 2024 | msn.comOno signs licence deal with NEX-I for cancer therapyFebruary 26, 2024 | finance.yahoo.comFate Therapeutics Inc (FATE) Reports Fourth Quarter and Full Year 2023 Financial ResultsFebruary 19, 2024 | markets.businessinsider.comInveniAI Announces Collaboration with Ono Pharmaceutical for Target DiscoveryFebruary 15, 2024 | finance.yahoo.comOno Pharmaceutical Co., Ltd. (OPHLY)February 14, 2024 | globenewswire.comNumab Therapeutics and Ono Pharmaceutical Announce an Option and Collaboration Agreement to Develop Multi-specific Antibody NM49 for Treatment of CancerFebruary 10, 2024 | barrons.comOno Pharmaceutical Co. Ltd.January 30, 2024 | markets.businessinsider.comOno Pharmaceutical earnings preview: what Wall Street is expectingJanuary 9, 2024 | finance.yahoo.comCall for Application to Researchers for Joint Research Project between Ono Pharmaceutical and BioMed XDecember 19, 2023 | finanznachrichten.deThe BioMed X Institute: BioMed X Institute and Ono Pharmaceutical Launch New Collaboration in Cancer ResearchNovember 28, 2023 | finance.yahoo.comNikkei Edges 0.2% Lower Amid JPY StrengthNovember 27, 2023 | finance.yahoo.comChina Shares Open Lower; Infrastructure Stocks WeighOctober 5, 2023 | msn.comOno Pharmaceutical Co. Ltd - ADR (OPHLY) Price Target Increased by 10.78% to 7.59August 31, 2023 | finance.yahoo.comTwist Bioscience Enters into Agreement with Ono Pharmaceutical to Discover Novel Antibodies for Autoimmune DiseasesAugust 31, 2023 | markets.businessinsider.comTwist Bioscience To Develop Novel Antibodies With Ono PharmaAugust 9, 2023 | finance.yahoo.comQ2 2023 Fate Therapeutics Inc Earnings CallAugust 3, 2023 | msn.comOno Pharmaceutical Co. Ltd - ADR (OPHLY) Price Target Decreased by 29.33% to 6.89March 23, 2023 | technews.tmcnet.comMacomics and Ono Pharmaceutical Partner to Discover and Develop Macrophage-targeting Antibody Therapy for the Treatment of CancerNovember 1, 2022 | benzinga.comMemo Therapeutics AG and Ono Pharmaceutical Enter Antibody Discovery Partnership for Immuno-oncology TargetsSeptember 19, 2022 | finance.yahoo.com3 Reasons Why Ono Pharmaceutical Co. (OPHLF) Is a Great Growth StockAugust 30, 2022 | seekingalpha.comFate Therapeutics: Yes For Speculators, No For Defensive InvestorsJuly 18, 2022 | benzinga.comOno Pharmaceutical (OTC:OPHLY), Earnings Estimates, EPS, and RevenueJuly 18, 2022 | benzinga.comOno Pharmaceutical (OTC:OPHLY), Analyst Ratings, Price Targets, PredictionsJuly 7, 2022 | uk.finance.yahoo.comCan Ono Pharmaceutical Co ride out the impact of economic shocks?January 23, 2022 | nasdaq.comOno Pharmaceutical Co. Ltd ADR (OPHLY)November 8, 2021 | markets.businessinsider.comHere's what to expect from ONO PHARMACEUTICAL's earnings report Get Ono Pharmaceutical News Delivered to You Automatically Sign up to receive the latest news and ratings for OPHLY and its competitors with MarketBeat's FREE daily newsletter. Email Address J.P. Morgan’s DIRE Warning (Ad)When the largest bank in the U.S. says a crisis is coming - you NEED to listen. The Wall Street Journal warns, "America's bonds are getting harder to sell." Click here to see why Wall Street is in PANIC mode >>> OPHLY Media Mentions By Week OPHLY Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. OPHLY News Sentiment▼0.000.62▲Average Medical News Sentiment OPHLY News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. OPHLY Articles This Week▼00▲OPHLY Articles Average Week Get Ono Pharmaceutical News Delivered to You Automatically Sign up to receive the latest news and ratings for OPHLY and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: AZNCF News DSNKY News JCRRF News KYKOF News MAYNF News OTSKF News RHHVF News SNYNF News VRBCF News TGIFF News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:OPHLY) was last updated on 7/26/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredWe recommended Nvidia in 2016, now we’re recommending this…The AI boom is just getting started. And the real wealth has still to be made…Porter & Company | SponsoredNEW AI developed by trader who won 1,129% (in 2 days)Earlier this year one legendary trader captured a 1,129% win (in just 2 days) ... LIVE in front of thousands o...Monument Traders Alliance | SponsoredBreaking News: Elon Musk Invents New Type of A.I. (Shocking)Could Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street vete...InvestorPlace | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock (June 12) This $2 trillion D.C. shock i...Timothy Sykes | SponsoredGrab a pen and write down this ticker - here's whyA megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made...StocksToTrade | SponsoredBrace Yourself: Experts calling for Bitcoin to hit $100kFor the past few months, Bitcoin has been trading flat… It's been stuck around the $60,000 to $72,000 range...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Ono Pharmaceutical Co., Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Ono Pharmaceutical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
